| Anne Barmettler, MD | |
|
3332 Rochambeau Ave Fl 3, Bronx, NY 10467-2836 | |
| (718) 920-2020 | |
| Not Available |
| Full Name | Anne Barmettler |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 16 Years |
| Location | 3332 Rochambeau Ave Fl 3, Bronx, New York |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336383538 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 274709 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Montefiore Medical Center | Bronx, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Montefiore Medical Center | 3779496021 | 2003 |
News Archive
Texas Heart Institute has been selected as one of up to 60 sites in the world to participate in an international investigative study seeking to aid COVID-19 patients who develop acute respiratory distress syndrome (ARDS).
Replacing faulty or missing cells with new insulin-making cells has been the object of diabetes research for the last decade. Past studies in tissue culture have suggested that one type of pancreas cell could be coaxed to transform into insulin-producing islet cells.
Intellipharmaceutics International Inc. today announced that Novartis Pharmaceuticals Corporation and Celgene Corporation have settled their patent suit in the U.S. District Court for the District of New Jersey, and Elan Pharma International Ltd. has settled its patent suit in the U.S. District Court for the District of Delaware, with Intellipharmaceutics Corp., a wholly-owned subsidiary of Intellipharmaceutics International, and its licensee Par Pharmaceutical, Inc. over a generic version of the Attention Deficit Hyperactivity Disorder drug Focalin XR® (dexmethylphenidate hydrochloride).
Britain's cutting of foreign assistance "is not … just a game of percentages; or a simple set of myths that can be countered to decide whether we spend 0.7 or 0.44 or even 0.01 percent of our national income on 'aid,'" Joe Cerrell, director of the Bill & Melinda Gates Foundation's Europe office, writes in a "Foundation Blog" post.
Latest insights into immunity to HIV could help to develop a vaccine to build antibodies' defences against the disease, a University of Melbourne, Australia study has found.
› Verified 5 days ago
| Entity Name | Montefiore Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063525152 PECOS PAC ID: 3779496021 Enrollment ID: O20031113000235 |
News Archive
Texas Heart Institute has been selected as one of up to 60 sites in the world to participate in an international investigative study seeking to aid COVID-19 patients who develop acute respiratory distress syndrome (ARDS).
Replacing faulty or missing cells with new insulin-making cells has been the object of diabetes research for the last decade. Past studies in tissue culture have suggested that one type of pancreas cell could be coaxed to transform into insulin-producing islet cells.
Intellipharmaceutics International Inc. today announced that Novartis Pharmaceuticals Corporation and Celgene Corporation have settled their patent suit in the U.S. District Court for the District of New Jersey, and Elan Pharma International Ltd. has settled its patent suit in the U.S. District Court for the District of Delaware, with Intellipharmaceutics Corp., a wholly-owned subsidiary of Intellipharmaceutics International, and its licensee Par Pharmaceutical, Inc. over a generic version of the Attention Deficit Hyperactivity Disorder drug Focalin XR® (dexmethylphenidate hydrochloride).
Britain's cutting of foreign assistance "is not … just a game of percentages; or a simple set of myths that can be countered to decide whether we spend 0.7 or 0.44 or even 0.01 percent of our national income on 'aid,'" Joe Cerrell, director of the Bill & Melinda Gates Foundation's Europe office, writes in a "Foundation Blog" post.
Latest insights into immunity to HIV could help to develop a vaccine to build antibodies' defences against the disease, a University of Melbourne, Australia study has found.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anne Barmettler, MD 2728 Thomson Ave Unit 514, Long Island City, NY 11101-2931 Ph: (978) 886-7122 | Anne Barmettler, MD 3332 Rochambeau Ave Fl 3, Bronx, NY 10467-2836 Ph: (718) 920-2020 |
News Archive
Texas Heart Institute has been selected as one of up to 60 sites in the world to participate in an international investigative study seeking to aid COVID-19 patients who develop acute respiratory distress syndrome (ARDS).
Replacing faulty or missing cells with new insulin-making cells has been the object of diabetes research for the last decade. Past studies in tissue culture have suggested that one type of pancreas cell could be coaxed to transform into insulin-producing islet cells.
Intellipharmaceutics International Inc. today announced that Novartis Pharmaceuticals Corporation and Celgene Corporation have settled their patent suit in the U.S. District Court for the District of New Jersey, and Elan Pharma International Ltd. has settled its patent suit in the U.S. District Court for the District of Delaware, with Intellipharmaceutics Corp., a wholly-owned subsidiary of Intellipharmaceutics International, and its licensee Par Pharmaceutical, Inc. over a generic version of the Attention Deficit Hyperactivity Disorder drug Focalin XR® (dexmethylphenidate hydrochloride).
Britain's cutting of foreign assistance "is not … just a game of percentages; or a simple set of myths that can be countered to decide whether we spend 0.7 or 0.44 or even 0.01 percent of our national income on 'aid,'" Joe Cerrell, director of the Bill & Melinda Gates Foundation's Europe office, writes in a "Foundation Blog" post.
Latest insights into immunity to HIV could help to develop a vaccine to build antibodies' defences against the disease, a University of Melbourne, Australia study has found.
› Verified 5 days ago
Sunju Park, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 3400 Bainbridge Ave, Bronx, NY 10467 Phone: 718-920-2020 | |
Dr. Jonathan Philip Levine, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 111 E 210th St, Dept Of Ophthalmology, Bronx, NY 10467 Phone: 718-920-2020 | |
Dr. Alexander Traykovski, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1650 Grand Concourse, Bronx, NY 10457 Phone: 718-518-5300 Fax: 718-239-8395 | |
Dr. Elizabeth Ting Ting Viriya, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1650 Grand Concourse, Bronx, NY 10457 Phone: 917-748-9167 | |
Dr. Gene Kim, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 3400 Bainbridge Ave, Bronx, NY 10467 Phone: 718-920-4428 | |
Dr. Pearl Rosenbaum, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3333 Henry Hudson Pkwy, Suite 5, Bronx, NY 10463 Phone: 718-548-5800 | |
Dr. Reginald Alivia Camillo, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1739 Williamsbridge Rd, Bronx, NY 10461 Phone: 718-824-1560 |